SCARB1 and sarcoma: In addition, our study demonstrated for the first time that the expression of SR-B1 was significantly higher in liposarcomas than in non-lipomatous sarcomas (p = 0.000), suggesting that SR-B1 may serve as a biomarker for distinguishing between liposarcomas from non-lipomatous sarcomas.